Squamous cell carcinoma of the maxillary sinus: A retrospective analysis of 36 cases.

  • Desiderio Passali
  • Bruno De Capua
  • Albertina De Lauretis
  • Enrico Tucci
  • Roberto Petrioli
  • Luisa Bellussi
  • Guido Franci
Lead Article


36 patients with advanced squamous cell carcinomas of the maxillary sinuses formed the basis of this review. There were 16 T3 and 20 T4. Treatment consisted of radiotherapy alone in 21 cases and radiotherapy followed by systemic chemotherapy in 15 cases. The median survival for all analysed patients was 19 months and the 3-year and 5-year estimated survivals were 30% and 17%. The respective 3-and 5-year survival probabilities were 19% and 9% for patients treated with radiotherapy alone and 40% and 27% for patients treated with radiotherapy and chemotherapy (p= 0.01). Our findings seem to suggest that the addititon of systemic chemotherapy to radiotherapy may imporve overall survival in advanced squamous cell carcinomas of the maxillary sinuses.


Neck Cancer Paranasal Sinus Maxillary Sinus Chemotherapy Group Advanced Squamous Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Muir CS, Nectoux J (1980): Descriptive epidemiology of malignant neoplasms of nose, nasal cavities, middle ear and accessory sinuses. Clin. Otolaryngol 5: 195–211.PubMedCrossRefGoogle Scholar
  2. 2.
    Sisson GA, Toriumi DM, Atiyah RA, (1989): Paranasal sinus malignancy: A comprehensive update. Laryngoscope 99: 143–150.PubMedGoogle Scholar
  3. 3.
    Robin PE, Powell DJ. (1981): Treatment of carcinoma of the nasal cavity and paranasal sinuses. Clin, Otolaryngol 6: 401–414.CrossRefGoogle Scholar
  4. 4.
    Harrison LB, Pfister DG, Fass DE, et al (1991): Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer. INT. J. Radiat, Oncol. Biol. Phys 21: 703–708.Google Scholar
  5. 5.
    Lo Russo P, Tapazoglou E, Kish JA, et al (1988): Chemotherapy for paranasal sinus carcinoma. A 10-year experience at Wayne State University. Cancer. 62: 1–5.CrossRefGoogle Scholar
  6. 6.
    American Joint Committee on Cancer. (1983) An Manual for staging of Cancer. J.B. Lippincott Co, Philadelphia. 43–48.Google Scholar
  7. 7.
    Drelichman A, Cummings G, Al Sarraf M (1983):A randomized trial of the combination of cisplatin, oncovin and bleomycin (COB) vs. methotrexate in patients with advanced squamous cancer of the head and neck. Cancer. 52: 399–403.PubMedCrossRefGoogle Scholar
  8. 8.
    Amer MH, Al-Sarraf M, Vaitkevicius VJ. (1979): Factors that affect response to chemotherapy and survival of patients with head and neck cancer. Cancer. 22: 2202–2206.CrossRefGoogle Scholar
  9. 9.
    Kish JA, Weaver A, Jacobs J, et al (1984) Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidemoid cancer of the head and neck. Cancer 53; 1819–1824.PubMedCrossRefGoogle Scholar
  10. 10.
    Kalplan EL, Meier P. (1958): Non parametric estimation for incomplete observations. J. AM. Stat Assoc. 53: 457–481.CrossRefGoogle Scholar
  11. 11.
    Peto R, Pke MC, Armitage P, et al (1977): Design and analysis of randomized clinical trials requiring prolonged observation of each patient. BR, J. Cancer 35: 1–39.Google Scholar
  12. 12.
    Cox DR, (1972): Regression models and life-tables. J. R. Stat Soc (B) 34: 187–220.Google Scholar
  13. 13.
    Lavertu P, Roberts JK, Kraus DH, et al (1989): Squamous cell carcinoma of the paranasal sinuses: the Cleveland Clinic experience 1977–1986. Laryngoscope. 99: 1130–1136.PubMedCrossRefGoogle Scholar
  14. 14.
    Giri SPG, Reddy EK, Gemer LS, et al (1991): Management of advanced squamous cell carcinoma of the maxillary sunns. Cancer 69; 657–661.CrossRefGoogle Scholar
  15. 15.
    Sato Y, Morita M, Takahashi H, et al (1970): I. Combined surgery, radiotherapy and regional chemotherapy in carcinomas of the paranasal sinuses. Cancer. 25: 571–579.PubMedCrossRefGoogle Scholar
  16. 16.
    Shafir M, Raventos E. (1983): Combination multimodality (surgery, radiotherapy, intra-arterial chemotherapv) treatment of advanced carcinoma of paranasal sinuses. Recent Results. Cancer Res. 86: 165–168.PubMedGoogle Scholar
  17. 17.
    Vokes EE, Weichselbaum RR, Mick R, et al. (1992): Favorable long-term survival following induction chemotherapv with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. I. Natl Cancer Inst. 84: 877–882.CrossRefGoogle Scholar
  18. 18.
    Schuller DE, Metch B, Stein DW, et al (1988): Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology group. Laryngoscope. 98: 1205–1211.PubMedCrossRefGoogle Scholar
  19. 19.
    Frich IC (1982) Treatment of advanced squamous carcinoma of the maxillary sinus by irradiation. INT. J. Radial Oncol. Biol. Phys 8; 1453–1459.Google Scholar
  20. 20.
    Jesse RH (1965): Pre-operative versus post-operative radiation in the treatment of squamous carcinoma of the paranasal sinuses. AM. J surg 110: 552–556.PubMedCrossRefGoogle Scholar

Copyright information

© Association of Otolaryngologists of India 1999

Authors and Affiliations

  • Desiderio Passali
    • 1
  • Bruno De Capua
    • 1
  • Albertina De Lauretis
    • 1
  • Enrico Tucci
    • 1
  • Roberto Petrioli
    • 2
  • Luisa Bellussi
    • 2
  • Guido Franci
    • 2
  1. 1.ENT, Radiotherpy DepartmentUniversity of SienaSienaItaly
  2. 2.Institute of Medical Pathology, Medical Oncology DivisionUniversity of SienaSienaItaly

Personalised recommendations